Introduction {#s1}
============

Breast cancer is the most common type of cancer in women and the main cause of death for them.^[@R1]^ Early detection of cancer cells can significantly decrease mortality of cancer and will be beneficial for patients. SPIONs are important nano-carriers that have greatly attracted researchers' attention due to their various functionality such as imaging, drug delivery, gene delivery, and hyperthermia.^[@R2]^ Because of their easy targeting characteristic by an external magnetic field, SPIONs can be used for the diagnosis and treatment of different diseases such as cancer and can be employed as drug-delivery carriers.^[@R3],[@R4]^ The size and morphology of SPIONs play important roles in all their unique characteristics. The aggregation of SPIONs can occur due to their high surface-to-volume ratio and their magnetic property. These phenomena lead to their opsonizaion and elimination from the body. Therefore, it is fundamental to engineer the surface of SPIONs.^[@R5]^ The most common coatings layer for SPIONs includes gold and silica. These coating layers can stabilize SPIONs and decrease the erosion effect of the environment.^[@R6]^ Furthermore, surface modification of SPIONs with gold makes them suitable candidates for photothermal therapy of tumor due to their strong absorbance in the NIR electromagnetic spectrum.^[@R7]^ In addition to photothermal advantages, gold surface engineered SPIONs have low cell toxicity for normal cells.^[@R8]^ To improve the accumulation of NPs in the desired tissue, they can be conjugated with functional moiety such as antibody,^[@R9]-[@R11]^ peptide,^[@R12]^ aptamer ^[@R13]-[@R18]^ and folic acid ^[@R19],[@R20]^ that can target overexpressed receptors onto cancerous cells. Among these targeting agents, aptamers have attracted great attention due to their favorable properties such as small size, low immunogenicity, low synthesis cost and high binding affinity.^[@R21]^ Due to these outstanding properties, aptamers have been employed as unique targeting moieties in nano-carrier systems. MUC-1 is a single stranded, DNA based aptamer that has been used as a targeting agent via different kinds of NPs on a broad range of epithelial cancer cells such as breast, colon, lung and prostate cancer.^[@R22]^

In this study, we developed SPIONs via microemulsion method and modified the surface of NPs with gold. The DNA based MUC-1 aptamer was conjugated on the surface of NPs to increase specificity of NPs delivery into cancerous cells. The targeting efficiency of MUC-1 conjugated NPs was assessed *in vitro* through confocal microscopy and flow cytometry. Finally, the therapeutic effect of gold coated NPs was investigated through irradiation of NIR light. To achieve this aim, cells were treated by gold coated NPs and their cell viability was examined after exposure to NIR light.

Materials and Methods {#s2}
=====================

Cethyltrimethylammonium bromide (CTAB), FeCl~2~.4H~2~O, FeCl~3~.6H~2~O, HAuCl, NH~2~OH.HCl, dithiotreitol (DTT), sodium citrate, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), Tris buffer acetate-EDTA (TAE), dimethyl sulfoxide (DMSO) and DAPI dye were purchased from Sigma, USA. Ethidium bromide and LysoTracker Red DND-99 were obtained from Life Technologies, USA. Human breast cancer (MCF-7) and Chinese hamster ovarian (CHO) cells were purchased from Pasteur Institute, Iran. DMEM medium and fetal bovine serum (FBS) were obtained from Gibco (Grand Island, USA). MUC-1 Aptamer as a targeting moiety was purchased from TAG Copenhagen A/S, Denmark. Amicon ultracentrifugal tube-Millipore (10 KDa) was purchased from Merck, Germany.

Synthesis of SPIONs and its surface modification {#s2-1}
------------------------------------------------

Among different kinds of SPIONs, magnetite (Fe~3~O~4~) and maghemite (γ-Fe~2~O~3~) are two most common types of this class. To synthesize SPIONs in this study, microemulsion method was selected due to its simplicity and ability to produce monodisperse Fe~3~O~4~ nanoparticle. The synthesis of Fe~3~O~4~ nanoparticle was performed according to our previously reported procedure.^[@R23]^ Briefly, 202 mg of FeCl~3~ and 75 mg of FeCl~2~ with molar ratio of 2:1 were poured into 2 ml of deionized water (DI) to produce aqueous phase. Subsequently, the prepared aqueous phase was added to 25 ml of toluene and 1.8 g CTAB to produce the first microemulsion. The second microemulsion was composed of toluene (25 ml) and CTAB (1.8 g) plus 25% ammonium hydroxide solution (2.5 ml). After preparing the mentioned microemulsions, each one was separately mixed at 7000 rpm using a homogenizer and titrated via 1-butanol (approximately 1.3 ml) until the color of solutions became transparent. Subsequently, the prepared microemulsions were poured into a three-necked flask and homogenized at 7000 rpm under constant flow of N2 gas at 50 °C. After 60 minutes, the homogenizer was stopped and the product was cooled down to room temperature. 20 ml ethanol was added to the flask and the prepared Fe~3~O~4~ nanoparticles were separated via a magnet. Finally, separated Fe~3~O~4~ nanoparticles were washed 3 times with boiling ethanol, 2 times with acetone and DI water. After the washing steps, Fe~3~O~4~ nanoparticles were dispersed at DI water via ultrasonic probe.

The surface of Fe~2~O~3~ nanoparticle was modified via gold based on Xu et al.^[@R24]^ procedure with minor modifications. For this purpose, prepared Fe~3~O~4~ nanoparticles -- which have little potency for gold coating -- were first heated and exposed to air for 1 hour to be oxidized to γ-Fe~2~O~3.~ At the first step of synthesis, HAuCl~4~·3H~2~O (2.5 mmol) was dissolved in chloroform (8 ml) and oleylamine (1 mmol). Subsequently, 8 ml chloroform solution containing 10 mg γ-Fe~2~O~3~ nanoparticles and oleylamine (1mmol) was prepared. At the next step, the HAuCl~4~ solution was poured dropwise into the γ-Fe~2~O~3~ nanoparticle solution. After 30 minutes, the gold coated γ-Fe~2~O~3~ nanoparticles were formed. By adding ethanol into the solution, the prepared gold coated γ-Fe~2~O~3~ nanoparticles were precipitated. To remove any residual, gold coated γ-Fe~2~O~3~ nanoparticles were washed 4 times with ethanol and hexane and dispersed in hexane. Finally, the gold coated γ-Fe~2~O~3~ nanoparticles were dried under vacuum and dispersed in aqueous solution which contains CTAB (0.1 M) and sodium citrate (0.1 mM) under sonication.

Physicochemical characteristic evaluation of NPs {#s2-2}
------------------------------------------------

Size and zeta potential of γ-Fe~2~O~3~ nanoparticles were measured by DLS (Malvern Zetasizer Nano ZS, UK) at a scattering angel of 90 θ at 25 °C. For this purpose, γ-Fe~2~O~3~ nanoparticles were suspended at DI water (pH=7.4) and sonicated for 5 min before measurement. The morphology and exact size of NPs were examined via TEM method (Philips EM 208, 90kv). TEM samples were prepared by adding one drop of NPs solution on a copper grid with carbon film.

Targeting of NPs with MUC-1 aptamer {#s2-3}
-----------------------------------

MUC-1 aptamer with oligonucleotide sequence of 5\'-HS-C~6~-GAG/ACA/AGA/ATA/AAC/GCT/CAA/GAA/GTG/AAA/ATG/ACA/GAA/CAC/AAC/ATT/CGA/CAG/GAG/GCT/CAC/AAC/AGGC-3\' was applied. At first, thiol modified aptamers were activated by adding DTT and 10 KDa Amicon tube was used to separate the activated aptamers. Aptamers were then suspended in Tris Buffer (50 mM Tris, 100mM NaCl). Afterwards, the activated aptamer solution (50 µM) was added to 0.5 ml of NPs (50 µg/ml) and incubated while was shaking for 24 h. After 24 h, the conjugated aptamer was separated from the free aptamer through centrifugation at 18000 g for 20 min and was later suspended in Tris buffer.

Agarose gel electrophoresis {#s2-4}
---------------------------

Aptamer conjugation was examined by agarose gel electrophoresis (2% w/v). In order to run samples into agarose gel, free aptamer solution, aptamer-NPs solution and bare NPs solution were mixed with a loading buffer (SDS, 2-ME, bromo phenol blue, glycerol, Tris HCl) and poured into agarose wells and run for 20 min at 110 V. Afterwards, the gel was soaked in a 0.5% ethidium bromide solution due to its ability to attach oligonucleotide and was visualized by a UV Transilluminator (Peqlab biotechnology gmbh, Germany).

Cell culture {#s2-5}
------------

MCF-7 and CHO Cells were cultured at 37 °C in 5% CO~2~ in DMEM medium supplemented with 10% FBS and 100 units/mL penicillin/streptomycin. The cells were seeded in 96 and 6 well plates and were grown to desired confluency.

Cytotoxicity assay {#s2-6}
------------------

MTT assay was used to examine cell toxicity of gold coated Fe~2~O~3~ nanoparticles. MCF-7 (MUC-1 positive cell line) and CHO (MUC-1 negative cell line) cells were seeded in 96 well plates (10000 cells per well) for 24 h in DMEM medium. Subsequently, the media were discarded and cells were treated with sterile NPs (conc. 10, 100 and 500 µg/ml) which had been suspended at free DMEM medium for 24 and 48 h. Later, the media were removed and each well was washed 3 times with PBS. Then, 100 µl of MTT solution (1 mg/ml) was added to each well and incubated for 2 h. Formazan crystals produced through addition of MTT reagent were dissolved by DMSO solvent and absorbance was read at 540 and 630 nm via ELISA reader (ELx800, BioTek instruments, USA). Six wells were used for each sample and cytotoxicity data were shown as mean ± SD. Mean absorbance of cells treated by NPs was divided by the mean absorbance of untreated Cell (control samples) to define cell viability of treated cells.

Aptamer-NPs targeting efficiency evaluation via confocal microscopy and flow cytometry method {#s2-7}
---------------------------------------------------------------------------------------------

Targeting efficiency of NPs was evaluated via confocal microscopy. For this purpose, cover glasses were placed in 6 well plates and 0.1% gelatin solution was poured into each well. After 1 h, the remaining gelatin was discarded. Subsequently, MCF-7 and CHO cells were seeded in wells and after 48 h, the media were removed. Aptamer-NPs and bare NPs (100 µg/ml) were added to each well of plates and incubated for 8 h. Afterwards, the media were removed and cells were washed with PBS. NPs uptake was evaluated with LysoTracker Red, which is a specific dye for the acidic organelles. Higher entrance of NPs into cells is correlated with higher amounts of endosome and lysosome in treated cells and higher intensity of fluorescence.^[@R25]^ Treated cells were stained with LysoTracker Red dye (300 nM) for 1 h and afterwards the solution was discarded and the cells were fixed by adding 0.4% formaldehyde solution for 20 min. Finally, cells were stained with DAPI solution for 5 min to specify the nucleus and the cover glasses were transferred onto the glass slides and examined by Nikon confocal microscope A1 (Nikon Inc., Switzerland) armed with an A1 scan head and a standard detector using a 405 nm diode laser with DAPI filter and 543 nm diode laser (Melles Griot, USA) with TRITC filter. Furthermore, NPs uptake was checked by flow cytometry instrument to quantitatively calculate NPs entrance to cells. For this purpose, cells were cultured in 6 well plates and later incubated with aptamer-NPs or bare NPs for 8 h. After that, the NP suspension was removed and the cells were stained by LysoTracker Red for 1 h. After the staining step, cells were trypsinized, centrifuged and suspended in PBS and analyzed by flow cytometry (Partec PASII, Germany).

Photothermal therapy {#s2-8}
--------------------

MCF-7 and CHO cells were seeded in a 6 well plate (400000cell per each well) and were then incubated with 1 ml of aptamer-NPs (100, 200 and 500 µg/ml in DMEM medium) at 37 °C, 5% CO^2^ for 12 h. Afterwards, the NP suspension was removed, cells were washed 3 times with PBS and fresh DMEM medium was added. Finally, treated cells were exposed to NIR light (640-710 nm, 0.7 W/cm^2^) via LED for 1-5 min. After NIR light exposure, cell viability was examined by MTT assay.

Results and Discussion {#s3}
======================

Physicochemical characteristics of NPs {#s3-1}
--------------------------------------

In recent years, promising physicochemical characteristics of SPIONs have made them outstanding nano-vehicles for different biomedical applications such as drug delivery,^[@R26]-[@R28]^ gene delivery,^[@R29]^ imaging,^[@R30],[@R31]^ stem cell tracking ^[@R32]^ and hypothermia.^[@R33]-[@R35]^ Such favorable properties of SPIONs result from their small size. SPIONs with the size of less than 25 nm act as mono-domain magnets and show their magnetic properties when they are exposed to an external magnetic field. In order to produce NPs with favorable size, we employed the microemulsion method. DLS measurements and TEM results illustrated that the average size of the Fe~2~O~3~ nanoparticles was 16 nm, which increased to approximately 22 nm after formation of the gold layer ([Figure 1](#F1){ref-type="fig"}). Zeta potential of Fe~2~O~3~ nanoparticles was -13mV and decreased to -17 mV after gold coating due to sodium citrate presence.

Surface modification of NPs via gold and its evaluation by UV-visible spectroscopy {#s3-2}
----------------------------------------------------------------------------------

The small size of SPIONs leads to large surface to volume ratio of these NPs and makes them vulnerable to aggregation.^[@R36]^ To overcome this drawback, gold layer ^[@R37],[@R38]^ was employed. In order to conjugate targeting agents or drugs to SPIONs, we needed functional groups on the surface of SPIONs and gold coating provides this characteristic. The gold layer provides easy attachment with thiol conjugated agents; in addition, its steady shell around SPIONs protects them against oxidation events.^[@R39]^ Furthermore, the gold shell around NPs makes them sensitive to light absorption.^[@R40]^ The formation of gold layer around Fe~2~O~3~ nanoparticles was double checked via UV-visible spectroscopy. The noticeable peak around 520-590 nm was confirmatory evidence for gold layer formation. [Figure 2](#F2){ref-type="fig"} illustrates that for gold coated NPs, there is a peak at 580 nm area and bare NPs spectrum is free of this peak.

Figure 1TEM images of (A) Fe~2~O~3~ nanoparticles and (B) Gold coated Fe~2~O~3~ nanoparticles. Size distribution analysis of (C) Fe~2~O~3~ nanoparticles, and (D) Gold coated Fe~2~O~3~ nanoparticles.

Figure 2UV-visible spectra of Fe~2~O~3~ nanoparticles and Gold coated Fe~2~O~3~ nanoparticles. The peak around 580 nm belongs to the gold coating around nanoparticles.

Gel electrophoresis to examine conjugation of aptamer to NPs surface {#s3-3}
--------------------------------------------------------------------

Aptamer-NPs, bare NPs and free aptamer were run through agarose gel electrophoresis to examine aptamer conjugation to the NPs. [Figure 3](#F3){ref-type="fig"} depicts that after addition of mentioned samples to agarose gel wells, aptamer-NPs stayed at loading well and was stained by adding ethidium bromide. Furthermore, the free aptamer sample moved freely through agarose gel and was stained by ethidium bromide while no distinct band related to bare NPs was detected. Due to their larger size, Aptamer-NPs, bare NPs could not pass through gel pores and were trapped in the loading wells. These results confirmed aptamer conjugation onto the NPs.

Figure 3Evaluation of aptamer conjugation onto gold coated Fe~2~O~3~ nanoparticles via agarose gel electrophoresis. (A) Ladder, (B) Free MUC-1 aptamer, (C) bare NPs, (D) Aptamer-NPs and (E) Aptamer-NPs (high concentration)

Cell viability of prepared NPs {#s3-4}
------------------------------

Due to their biocompatibility, SPIONs have been widely used for drug delivery purposes. Surface modification of these NPs with gold increases their biocompatibility.^[@R8]^ Cell viability of prepared NPs was evaluated via MTT assay and results ([Figure 4](#F4){ref-type="fig"}) indicated that 10 and 100 µg/ml concentrations of NPs have little effect on cell viability while increasing concentration to 500 µg/ml leads to more cell death.

NPs uptake evaluation via confocal microscopy and flow cytometry {#s3-5}
----------------------------------------------------------------

The cellular uptake of aptamer-NPs and bare NPs was investigated by MCF-7 (MUC-1 positive cell line) and CHO (MUC-1-negative cell line). Overexpression of MUC-1 glycoprotein at the surface of epithelial cancer cells such as MCF-7 cells provides a great opportunity to apply MUC-1 aptamer on the surface of NPs as an efficient targeting moiety. Cells were treated by NPs and their cellular uptake was evaluated by LysoTracker Red as a marker of lysosome organelle. Cellular uptake of particles led to increase of lysosome and endosome, which makes these organelles indicator of cellular uptake.^[@R25]^ MCF-7 cells incubated with aptamer-NPs show higher fluorescent intensity compared to cells treated with bare NPs while aptamer-NPs and bare NPs show no difference in entering CHO cells ([Figure 5](#F5){ref-type="fig"}). Furthermore, cellular uptake of NPs was quantitatively investigated by flow cytometry method ([Figure 6](#F6){ref-type="fig"}). The flow cytometry results indicated that mean fluorescence intensity of aptamer-NPs and bare NPs were 11.2 and 7.4 in the MCF-7 cells, respectively. Flow cytometry results of CHO cells shows similar mean fluorescence intensity for aptamer-NPs and bare NPs (8.7 compared to 7.3, respectively).

This is strong confirmatory evidence of targeting efficiency of aptamer-modified nanoparticles. The conjugated MUC-1 aptamer efficiently mediate attachment of NPs to cancer cells and their internalization.^[@R40]^

Figure 4In vitro cell viability measured via MTT assay. (Top) MCF-7 and (Bottom) CHO cells were incubated with gold coated Fe~2~O~3~ nanoparticles (10,100, 500 µg/ml conc.) for 24 and 48 h (n=6, data is shown as mean ± SD)

Cancerous cells eradication via photothermal therapy {#s3-6}
----------------------------------------------------

During this step, MCF-7 cells were treated for 8 hours with aptamer-gold coated Fe~2~O~3~ nanoparticles (100, 200 and 500 µg/ml). They were then exposed to NIR light by using a light emitting diode (LED) for 1-5 minutes. Control cells were defined as cells that were exposed via NIR light without NPs treatment. After NIR irradiation, MCF-7 cells treated with aptamer-NPs experienced more cytotoxicity compared to bare NPs, a fact which resulted from photothermal effect of gold coated Fe~2~O~3~ nanoparticles ([Figure 7](#F7){ref-type="fig"}). Internalization of gold coated NPs via desired cells makes them suitable targets for heat production after laser irradiation. While cancerous cells are more susceptible to heat, normal cells exhibit less susceptibility to heat, a fact which makes photothermal approach a safe and effective way to eradicate cancerous cells.^[@R41],[@R42]^ NIR irradiation can lead to DNA damage,^[@R43]^ ROS mediated apoptosis,^[@R44]^ disruption of plasma membrane ^[@R45]^ or depolarization of mitochondrial membrane ^[@R44]^ and finally cell death.

Figure 5Confocal microscopy images of treated cells (MCF-7 and CHO cell line) with NPs. Lysosomes were marked by LysoTracker Red as an indicator of NP uptake, nuclei stained blue by DAPI. (Scale bars are 50 µm).

Figure 6Flow cytometry results of cellular uptake of aptamer-NPs after staining of cells by LysoTracker Red as a marker of NPs uptake in (Left) MCF-7 (MUC-1 positive cell) and (Right)CHO (MUC-1 negative cell)

Figure 7Cytotoxicity of (Top) MCF-7 and (Bottom) CHO cells treated with different concentration of aptamer-NPs after exposure to NIR light through 1 to 5 minutes (n=3, Mean ± SD)

Conclusion {#s4}
==========

In summary, we have produced surface modified Fe~2~O~3~ nanoparticles and MUC-1 aptamer, as a targeted moiety conjugated onto gold layer around NPs. Confocal microscopy and flow cytometry method confirmed higher uptake of Aptamer-NPs compared to bare NPs in MUC-1 positive cells while aptamer-NPs and bare NPs exhibited similar cellular uptake in MUC-1 negative cells. In the final step, laser irradiation effectively eradicated cancer cells while normal cells experienced no harmful effects. Findings approve application of gold coated Fe~2~O~3~ nanoparticles as a biocompatible and efficient device in the field of cancer therapy.
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